Poland· PL-100430111
Sorafenib Zentiva
A sorafenib product containing sorafenibum, registered in Poland by Zentiva, k.s.. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Sorafenib is registered in 14 of 19 countries.
Countries holding a registration under ATC L01EX02 (sorafenib), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Sorafenib · ATC L01EX02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sorafenib costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sorafenib · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$125.31
The record
At a glance
URPL (Poland)- Active substance
- Sorafenibum
- Manufacturer
- Zentiva, k.s.
- Country
- Poland (PL)
- ATC code
- L01EX02
- ATC class
- Sorafenib
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991440145
- gtin08594739275324
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
598 interactions on record for sorafenib.
Graded by severity as the source publishes them — 85 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sorafenib · interactions on record
598 records
- 85 severe
- 352 moderate
- 11 minor
- 150 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- EdoxabanB01AF03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sorafenib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNEXAVARBayer AG, Leverkusen
- United StatesNexavarBayer HealthCare Pharmaceuticals Inc.
- NetherlandsFENESA 200 mg filmomhulde tablettenZentiva k.s.
- FinlandNexavarParanova Oy
- SpainNEXAVAR 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULABayer Ag
- FranceNEXAVAR 200 mg, comprimé pelliculéBAYER AG (ALLEMAGNE)
- SwedenNexavar 200 mg Filmdragerad tablettBayer AG
- BelgiumNexavar 200 mgBayer
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Sorafenib, Sorafenib Bluefish
- Belgium · Sorafenib Eg, Sorafénib Eg
- Bulgaria · Сорафениб Зентива, Сорафениб Тева
- Cyprus · Rexanib
- Czechia · Sorafenib Pharmagen, Sorafenib Sandoz
- Germany · Sorafeb, Sorafenib Abz
- Denmark · Sorafenib "sandoz", Sorafenib Stada
- Estonia · Sorafenib Sandoz, Sorafenib Teva
- Spain · Sorafenib Dr. Reddys, Sorafenib Eugia
- Finland · Sorafenib Sandoz, Sorafenib Stada
- France · Sorafenib Arrow, Sorafenib Biogaran
- United Kingdom (Northern Ireland) · Sorafenib Sandoz, Sorafenib Teva
- Greece · Revamox, Sorafenib Bioars
- Croatia · Slam 200 Mg Tablete, Sorafenib Alpha-Medical
- Hungary · Fenesa, Renixola
- Iceland · Nexavar, Sorafenib
- Italy · Sorafenib Eg, Sorafenib Medac
- Liechtenstein · Nexavar, Sorafenib Accord
- Lithuania · Sorafenib Sandoz, Sorafenib Teva
- Luxembourg · Sorafenib Eg, Sorafenib Eurogenerics
- Latvia · Sorafenib Lv System, Sorafenib Sandoz
- Malta · Revamox, Sorafenib Pharos
- Netherlands · Fenesa, Sorafeb
- Norway · Nexavar, Sorafenib Accord
- Portugal · Sorafenib, Sorafenib Eugia
- Romania · Sorafenib Dr. Reddy's, Sorafenib Sandoz
- Sweden · Sorafenib Bluefish, Sorafenib Sandoz
- Slovenia · Sorafenib Sandoz, Sorafenib Teva
- Slovakia · Sorafenib, Sorafenib Pharmagen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3c089bd5-418c-40aa-930a-29360520b685 GET /v1/drugs/3c089bd5-418c-40aa-930a-29360520b685?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "200 mg",
"packaging": "05909991440145 ¦ Rpz ¦ 137969\n112 tabl. w blistrze perforowanym\n08594739275324 ¦ Rpz ¦ 161451\n112 tabl. w blistrze",
"substance": "Sorafenibi Tosilas 274 mg",
"common_name": "Sorafenibum",
"pl_product_id": "100430111",
"pozwolenie_nr": "26074",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about sorafenib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.